Dataset from A Phase 3, Randomized, Multi-Center, Multi-National, Open-Label, Active Comparator Study to Evaluate the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007721
下载链接
链接失效反馈官方服务：
资源简介：
This Phase 3 study was designed to confirm the efficacy and safety of eliglustat tartrate
(Genz-112638) in participants with Gaucher disease type 1 who had reached therapeutic goals
with enzyme replacement therapy (ERT).
创建时间：
2024-11-26
